Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01882582 · ClinicalTrials.gov registry record
Evaluation of Immune Signaling Networks in Healthy Human Volunteers
A clinical trial, sponsored by Martin Angst.
- Completed
- Registry status
- 25
- Enrollment target
NCT01882582 is a clinical trial that has completed, run by Martin Angst. The registered enrollment target is 25 participants.
The verdict
NCT01882582 has completed, sponsored by Martin Angst.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand whether and to what extent the activity of immune cells in blood varies over time under normal conditions as assessed in healthy subjects. Results of this study will provide the foundation for helping us evaluate changes in immune cell activities in response to surgery and drugs used in anesthesia. The overall purpose of our research is to understand immune health in the context of anesthesia and surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01882582
The ClinicalTrials.gov registry entry for NCT01882582 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Martin Angst, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01882582 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01882582 about?
NCT01882582 is a clinical study titled "Evaluation of Immune Signaling Networks in Healthy Human Volunteers". The purpose of this study is to better understand whether and to what extent the activity of immune cells in blood varies over time under normal conditions as assessed in healthy subjects. Results of this study will provide the foundation for helping us evaluate changes in immune cell activities in ...
What is the current status of trial NCT01882582?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2012-08. Estimated completion is 2013-07.
Who is sponsoring clinical trial NCT01882582?
This trial is sponsored by Martin Angst, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.